Surgical Incision

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cogent Biosciences
1 program
REBUILDN/A1 trial
Active Trials
NCT05687942Not Yet Recruiting40Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Cogent BiosciencesREBUILD

Clinical Trials (1)

Total enrollment: 40 patients across 1 trials

The REBUILD Trial: Closure of the Abdominal Wall

Start: Mar 2023Est. completion: Jun 202640 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space